EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Drug resistance of Mycoplasma genitalium: mechanism and regional distribution

Yuhang Ouyang, Yujin Zhang, Zhixian Long, Xuan Wu, Ningyuan Li, Xulin Liu, Jin Lin, Yanan Niu, Jiaxin Chen, Jiaxuan Tang, Chunlan Xiao, Peng Liu und 2 weitere

Frontiers in Cellular and Infection Microbiology · 2026

DOI: 10.3389/fcimb.2026.1789671 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Yuhang Ouyang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control and Institute of Pathogenic Biology, Basic Medical School, Hengyang Medi…. Hauptthemen laut MEDLINE: Mycoplasma genitalium, Mycoplasma Infections, Drug Resistance, Bacterial, Anti-Bacterial Agents. Die Arbeit nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycoplasma genitalium is a significant sexually transmitted pathogen associated with various urogenital diseases and severe complications in both men and women. In recent years, advances in molecular diagnostic technologies have progressively revealed its global prevalence. Concurrently, the escalating issue of antibiotic resistance poses a major public health challenge. This review aims to summarize the clinical manifestations and resistance mechanisms of M. genitalium infection, the global epidemiological characteristics of antibiotic resistance, as well as the limitations and challenges of existing research, thereby providing a scientific basis for formulating effective control measures. Key acquired resistance mechanisms of M. genitalium include macrolide resistance due to 23S rRNA gene mutations; fluoroquinolone resistance triggered by parC and gyrA gene mutations; and tetracycline resistance associated with the mutations in the 16S rRNA gene. Major external drivers of resistance emergence and spread include antibiotic misuse, sexual transmission networks, latent transmission by asymptomatic carriers, and limitations in detection methods. In recent years, M. genitalium infections have been prevalent in many countries worldwide, with rising resistance rates observed in some regions. Resistance rates remain persistently high in Oceania, Asia, and parts of North America, while regions such as Africa exhibit relatively lower levels of resistance. The clinical management of M. genitalium infections exhibits significant heterogeneity across major countries in North America, Europe, and the Asia-Pacific region. These differences primarily stem from regional variations in antibiotic resistance patterns, drug accessibility, and differing approaches to antimicrobial stewardship. Antibiotic resistance in M. genitalium has become an urgent global public health issue. Future efforts should prioritize strengthening global collaboration on antimicrobial resistance surveillance, promoting the application of molecular epidemiological methods in future research, deepening research into resistance mechanisms, advancing rapid diagnostic technologies and novel drug development, and refining regional clinical management guidelines based on local resistance patterns to effectively curb this evolving threat.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycoplasma genitaliumMycoplasma InfectionsDrug Resistance, BacterialAnti-Bacterial AgentsHumansGlobal HealthRNA, Ribosomal, 23SPrevalenceMacrolidesFemale

Stichwörter der Autor:innen

Mycoplasma genitaliumantibiotic resistancefluoroquinolonesmacrolidesregional distributionresistance mechanisms

Substanzen

Anti-Bacterial AgentsRNA, Ribosomal, 23SMacrolides

Autor:innen und Institutionen

  • Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control and Institute of Pathogenic Biology, Basic Medical School, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
  • Department of Thyroid and Breast Surgery, Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital, Hengyang, Hunan, China.
  • Department of Clinical Laboratory Medicine, Institution of Microbiology and Infectious Diseases, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.

Zitieren

APA

Ouyang, Y., Zhang, Y., Long, Z., Wu, X., Li, N., Liu, X., Lin, J., Niu, Y., Chen, J., Tang, J., Xiao, C., Liu, P., Zhang, Y., & Gong, W. (2026). Drug resistance of Mycoplasma genitalium: mechanism and regional distribution. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1789671

Vancouver

Ouyang Y, Zhang Y, Long Z, Wu X, Li N, Liu X, et al. Drug resistance of Mycoplasma genitalium: mechanism and regional distribution. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1789671

BibTeX
@article{Ouyang2026,
  author = {Ouyang, Yuhang and Zhang, Yujin and Long, Zhixian and Wu, Xuan and Li, Ningyuan and Liu, Xulin and Lin, Jin and Niu, Yanan and Chen, Jiaxin and Tang, Jiaxuan and Xiao, Chunlan and Liu, Peng and Zhang, Yaliu and Gong, Weidong},
  title = {Drug resistance of Mycoplasma genitalium: mechanism and regional distribution},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  doi = {10.3389/fcimb.2026.1789671}
}
Kostenlos starten →